Arecor Therapeutics annual operating margin
2022
2023
2024
2025
Arecor Therapeutics Operating Margin Growth & History (AREC)
Arecor Therapeutics's operating margin was −236.00% for fiscal 2025.
View full Arecor Therapeutics company overviewArecor Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −236.00% | +79.04 pp |
| 2024 | 2024-12-31 | −315.03% | −114.40 pp |
| 2023 | 2023-12-31 | −200.63% | +236.82 pp |
| 2022 | 2022-12-31 | −437.45% | — |
Arecor Therapeutics operating margin trends
Between the periods ended 2022-12-31 and 2025-12-31, Arecor Therapeutics's operating margin increased from −437.45% to −236.00%, a change of +201.46 percentage points.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as reported operating income divided by reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Arecor Therapeutics source filings ↗Community posts
Arecor conditionally raises £5 million to extend insulin-development funding
Arecor Therapeutics ($AREC-LSE) has conditionally placed approximately 7.35 million new shares at 68 pence each, raising about £5 million before expenses. The financing follows an accelerated bookbuild and is separate from a planned retail ...
